HIV/AIDS Clinical Trials Network Clinical Trials Units (UM1 Clinical Trial Required)
Issued by National Institutes of Health · via Grants.gov — US federal funding opportunities
- Published
- 20 Nov 2026
- Closes
- 9 Mar 2027, 23:59 UTC
- Value
- USD 60,000,000
- Reference
- RFA-AI-28-004
- Location
- United States
- Sector
- Healthcare & Pharma
At a glance
National Institutes of Health in United States has published a funding call in healthcare & pharma: “HIV/AIDS Clinical Trials Network Clinical Trials Units (UM1 Clinical Trial Required)”. Submissions close on 9 March 2027, 109 days from today. The stated value is USD 60,000,000. Quote reference RFA-AI-28-004 in any correspondence with the buyer. FreeTender has recorded 463 notices from this buyer since 2023, 361 of them currently open. There are 367 open healthcare & pharma notices in United States on FreeTender. Bids are submitted to the buyer through Grants.gov — US federal funding opportunities, not through FreeTender.
Key requirements
Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.
To bid on Grants.gov (US federal)
Applicants need a UEI from SAM.gov and a Grants.gov account registered to their organisation; allow several weeks for registration.
Details
The purpose of this notice of funding opportunity (NOFO) is to support HIV/AIDS Clinical Trials Network Clinical Trials Units (CTUs). CTUs will provide the infrastructure, as well as the scientific and administrative expertise to conduct clinical studies developed by NIH HIV/AIDS Clinical Trials Networks to advance research in the prevention and treatment of HIV and HIV-associated diseases. CTUs will participate in multiple clinical research studies, accessing relevant populations most heavily impacted by the HIV/AIDS epidemic and studies of highest priority to NIH. Eligibility: Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Estimated total programme funding: USD 60000000
Expected number of awards: 65
CFDA number(s): 93.242
Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.
Context for bidders
We hold 463 notices from National Institutes of Health, going back to May 2023 — 361 of them still open. They buy mostly in Healthcare & Pharma, Education & Training and Water & Environment. There are 367 open Healthcare & Pharma tenders in United States. This one closes in 109 days.
More from this buyer
- HIV/AIDS Clinical Trials Network Laboratory Centers (UM1 Clinical Trial Required)· closes 9 Mar
- HIV/AIDS Clinical Trials Network Leadership and Operations Centers (UM1 Clinical Trial Required)· closes 9 Mar
- HIV/AIDS Clinical Trials Network Statistical and Data Management Centers (UM1 Clinical Trial Required)· closes 9 Mar
- Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (UM1 Clinical Trial Required)· closes 10 Jun
- NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)· closes 20 Feb
Similar Healthcare & Pharma tenders
- Research Grants Supporting Scientific Discovery, Academic Research and New Studies· closes 18 Jan
- Face Plate Assembly — 38 each, NSN 4240016556723· closes 30 Nov
- New Reference Lab Testing | Legacy VISN 15· closes 18 Dec
- Human Resources Division Mobile Health Service· closes 23 Nov
- Loma Linda FDG — Drugs and Biologicals· closes 2 Dec
Explore United States
Before you bid on this tender
A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.
- Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
- Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
- Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
- Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
- Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
- Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
More Healthcare & Pharma tenders
- Supply of Human Medicine and Laboratory Reagents at Bank of Tanzania, Dodoma.BANK OF TANZANIA - DODOMA HEAD OFFICE · Tanzania
- Supply of General Cleaning MaterialsMOROGORO REGIONAL REFFERAL HOSPITAL · Tanzania
- Procurement of Medical Supplies Items from ManufacturersMEDICAL STORES DEPARTMENT · Tanzania
- Supply of Laboratory Equipment and InstrumentsGEOLOGICAL SURVEY OF TANZANIA · Tanzania
- Procurement of Consumable medical supplies for HospitalMOUNT MERU REGIONAL REFFERAL HOSPITAL (ARUSHA) · Tanzania
FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.
Verify & apply on the official portal →